A5026930806- BRCA gene mutations in cancer
- Digital Radiography and Breast Imaging
- Cancer Genomics and Diagnostics
- MRI in cancer diagnosis
- Breast Lesions and Carcinomas
- AI in cancer detection
- Genomic variations and chromosomal abnormalities
- Breast Cancer Treatment Studies
- Medical Imaging Techniques and Applications
- Cancer Risks and Factors
- Radiomics and Machine Learning in Medical Imaging
- Lymphadenopathy Diagnosis and Analysis
- Advanced Neuroimaging Techniques and Applications
- Genetics, Bioinformatics, and Biomedical Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Advanced X-ray and CT Imaging
- Lymphoma Diagnosis and Treatment
- Pleural and Pulmonary Diseases
- Cancer and Skin Lesions
- Cancer Cells and Metastasis
- Gene expression and cancer classification
- Biomedical and Engineering Education
- Global Cancer Incidence and Screening
- Congenital Diaphragmatic Hernia Studies
- Cutaneous lymphoproliferative disorders research
Sheba Medical Center
2016-2024
Tel Aviv University
2017-2023
Baylor College of Medicine
1987
Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense BreastsVera Sorin1,2, Yael Yagil1,2, Ady Yosepovich2,3, Anat Shalmon1,2, Michael Gotlieb1,2, Osnat Halshtok Neiman1,2 Miri Sklair-Levy1,2Audio Available | Share
Following vaccination of Israeli population with Pfizer-BioNTech COVID-19 Vaccine, an unusual increase in axillary-lymphadenopathy was noted. This study assesses the rate and magnitude this trend from breast-imaging standpoint.Participants undergoing breast-imaging, whom isolated detected were questioned regarding SARS-CoV-2 vaccine to ipsilateral arm. Patients' imaging characteristics statistically compared. In order perform a very short-term follow-up, twelve healthy vaccinated medical...
Background Pregnancy‐associated breast cancer (PABC) is often a delayed diagnosis and contrast‐enhanced MRI contraindicated because gadolinium agents are known to cross the placenta. Purpose To investigate feasibility clinical utility of noncontrast using diffusion tensor imaging (DTI) in diagnostic workup PABC. Study Type Prospective. Population Between November 2016 January 2018, 25 pregnant participants (median gestational age: 17 weeks) were recruited from eight referral breast‐care...
To compare the abilities of ultrasonography (US) and magnetic resonance imaging (MRI) in diagnosing silicone lymphadenopathy.Consecutive patients with breast implants who underwent axillary intramammary lymph node core needle biopsies were retrospectively collected (December 2011-May 2017). Ultrasonographic examinations analyzed for presence US snowstorm sign, MRI evaluated signal. A pathologist reviewed all biopsied specimens. evaluations compared to pathologic results. The sensitivity...
A pacemaker may affect the utility of a mammogram in several ways. The aim this study is to summarize our institution's experience with mammograms among patients cardiac pacemaker, focusing on diagnostic workup newly diagnosed ipsilateral breast cancer.A retrospective search all mammography reports between January 2011 and April 2021 was conducted for identifying cases pacemaker. Demographic clinical characteristics as well mammography-derived quality parameters findings were categorized...
Background. While BRCA1/BRCA2 pathogenic sequence variants (PSVs) clearly confer an increased risk for invasive breast cancer, the extent to which these mutant alleles increase DCIS is less clear. Objective. To assess rate of detection over a 5-year period, and MRI imaging features pure noncalcified in cohort Israeli PSV carriers attending high-risk clinic from 2015 2020. Materials Methods. All female PSV-carriers followed at Meirav High-risk 2020 were eligible if they underwent semiannual...
Female BRCA1/BRCA2 mutation carriers may elect bilateral risk-reducing mastectomy. There is a paucity of data on yield imaging surveillance after This retrospective study focused female who underwent mastectomy either as primary preventative, or secondary breast cancer diagnosis. All participants at 6- to 12-month intervals Data subsequent diagnosis and timing were collected compared between the groups. Overall, 184 (134 BRCA1, 45 BRCA2, 5 both BRCA genes) initial diagnosis, April 1, 2009...
A semi-annual surveillance scheme from age 25 to 30 years is offered BRCA1/BRCA2 pathogenic sequence variants (PSVs) carriers for early detection of breast cancer (BC). There a paucity data on the yield adhering this beyond 70 age.
<title>Abstract</title> Purpose A semi-annual surveillance scheme from age 25–30 years is offered to <italic>BRCA1/BRCA2</italic> pathogenic sequence variants (PSVs) carriers for early detection of breast cancer (BC). There a paucity data on the yield adhering this beyond 70 age. Methods Female PSV followed at Meirav high-risk clinic, Sheba Medical center, Israel were eligible. Type and frequencies if use Imaging modalities, biopsies histological outcomes participants after retrieved...
Abstract Background. Neoadjuvant chemotherapy (NACT) is increasingly administered for high-risk breast cancer patients. Yet, oncologists lack an effective method assessing response to treatment beyond clinicpathological features. Organ tissue slices freshly obtained from the tumor and incubated in appropriate media, recapitulate tumor’s heterogeneity may provide a superior ex-vivo model predicting response/resistance treatment. While these models were tested metastatic tumors, no studies up...